Psykolog Luise Bæk Bomme ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  22.5% 9.0% 8.1% 9.3% 7.3%  
Credit score (0-100)  5 27 29 26 32  
Credit rating  B BB BB BB BBB  
Credit limit (kDKK)  -0.0 -0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  44.1 259 421 625 516  
EBITDA  -55.3 -71.3 -28.5 46.4 -24.4  
EBIT  -56.9 -71.3 -28.5 46.4 -24.4  
Pre-tax profit (PTP)  -56.9 -73.4 -33.7 42.5 -25.2  
Net earnings  -56.9 -57.3 -13.9 33.0 -20.1  
Pre-tax profit without non-rec. items  -56.9 -73.4 -33.7 42.5 -25.2  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -56.7 -114 -88.9 44.1 23.9  
Interest-bearing liabilities  51.0 153 141 1.5 1.5  
Balance sheet total (assets)  6.4 103 104 184 136  

Net Debt  44.7 81.3 85.8 -114 -2.1  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  -100.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  44.1 259 421 625 516  
Gross profit growth  0.0% 487.8% 62.4% 48.3% -17.4%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  6 103 104 184 136  
Balance sheet change%  407.9% 1,518.8% 1.4% 75.8% -25.9%  
Added value  -55.3 -71.3 -28.5 46.4 -24.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -2 0 0 0 0  

Net sales trend  -1.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 -4.0 1.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -129.0% -27.5% -6.8% 7.4% -4.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -177.0% -50.9% -13.9% 24.6% -15.2%  
ROI %  -217.8% -70.0% -19.4% 49.7% -68.6%  
ROE %  -1,728.5% -104.9% -13.4% 44.4% -59.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -89.9% -52.6% -46.0% 24.0% 17.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -80.7% -114.0% -300.7% -245.0% 8.8%  
Gearing %  -90.0% -134.0% -158.9% 3.5% 6.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 2.1% 3.5% 5.5% 52.7%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.1 0.4 0.5 1.3 1.0  
Current Ratio  0.1 0.4 0.5 1.3 1.0  
Cash and cash equivalent  6.4 71.5 55.4 115.3 3.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -56.7 -122.6 -97.5 35.5 1.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -55 -71 -29 46 -24  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -55 -71 -29 46 -24  
EBIT / employee  -57 -71 -29 46 -24  
Net earnings / employee  -57 -57 -14 33 -20